Specifications
Species Reactivity
Mouse; Rat; Human
Immunogen
Synthetic peptide within Human PAK3 aa 1-100 (N terminal). The exact sequence is proprietary.
Applications
Application Notes
Recommended concentration:
WB: 1/10000 - 1/50000
IHC-P: 1/100 - 1/250
Target
Alternative Names
PAK3; p21 protein (Cdc42/Rac)-activated kinase 3; mental retardation, X linked 47 , MRX30, MRX47, p21 (CDKN1A) activated kinase 3; serine/threonine-protein kinase PAK 3; bPAK; hPAK3; PAK-3; beta-PAK; oligophrenin-3; p21-activated kinase 3; p21 (CDKN1A)-a
Product Background
Antigen Description
PAK proteins are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. PAK proteins serve as targets for the small GTP binding proteins Cdc42 and RAC and have been implicated in a wide range of biological activities. PAK3 forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1 proteins which then catalyzes a variety of targets. It may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. A point mutation in this gene has been linked to nonsyndromic X-linked mental retardation.
Pathway
Activation of Rac, organism-specific biosystem; Axon guidance, organism-specific biosystem; Axon guidance, conserved biosystem; Axon guidance, organism-specific biosystem; Developmental Biology, organism-specific biosystem; ErbB signaling pathway, organism-specific biosystem; ErbB signaling pathway, conserved biosystem;
Citations
Publication ()
Have you cited DCABH-8823 in a publication?
Let us know and earn a reward for your research.